HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 15,770
+180 (1.15%)
At close: Dec 5, 2025
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 221.45 billion as of December 5, 2025. Its market cap has decreased by -12.63% in one year.
Market Cap
221.45B
Enterprise Value
211.79B
Revenue
36.10B
Ranking
n/a
PE Ratio
468.52
Stock Price
15,770.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 221.45B, an increase of 162.75%. That is a compound annual growth rate of 10.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 221.45B | -34.56% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | 240.12B | 219.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 75.96T |
| Celltrion | 40.11T |
| ALTEOGEN | 24.41T |
| ABL Bio | 10.51T |
| SK Biopharmaceuticals | 10.49T |
| Yuhan | 8.76T |
| LigaChem Biosciences | 6.75T |
| Peptron | 6.65T |